NLM Digital Collections

Search

Start Over Subjects United States. Department of Health and Human Services. ✖Remove constraint Subjects: United States. Department of Health and Human Services. Languages English ✖Remove constraint Languages: English

141. Medicaid program integrity: CMS should build on current oversight efforts by further enhancing collaboration with states : report to the Chairman, Committee on Finance, U.S. Senate

Publication:
Washington, D.C. : U.S. Government Accountability Office, March 2017
Subject(s):
Financial Audit
Fraud -- prevention & control
Insurance, Health, Reimbursement
Medicaid -- economics
Program Evaluation
Contract Services
Managed Care Programs
State Government
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

142. Pediatric trauma centers: availability, outcomes, and federal support related to pediatric trauma care : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, March 2017
Subject(s):
Emergency Medical Services -- statistics & numerical data
Health Services Accessibility
Outcome Assessment (Health Care)
Pediatrics
Trauma Centers
Wounds and Injuries -- therapy
Child
Financing, Government
Hospital Mortality
Humans
United States
United States. Department of Health and Human Services.
United States. Health Resources and Services Administration.
National Institutes of Health (U.S.)

143. Health care: telehealth and remote patient monitoring use in Medicare and selected federal programs : report to Congressional committees

Publication:
Washington, D.C. : U.S. Government Accountability Office, April 2017
Subject(s):
Health Services Accessibility
Medicare
Telemedicine
Telemetry
Insurance Coverage
Insurance, Health, Reimbursement
Medicaid
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

144. Medicaid demonstrations: federal action needed to improve oversight of spending : report to the Chairman, Committee on Finance, U.S. Senate

Publication:
Washington, D.C. : U.S. Government Accountability Office, 2017
Subject(s):
Health Expenditures
Medicaid -- economics
Pilot Projects
Cost Control
Federal Government
Government Regulation
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

145. Medicare advantage: CMS should use data on disenrollment and beneficiary health status to strengthen oversight : report to Congressional Requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, April 2017
Subject(s):
Health Status
Insurance Selection Bias
Medicare Part C -- statistics & numerical data
Government Regulation
Risk
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

146. Medicaid personal care services: more harmonized program requirements and better data are needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, May 2, 2017
Subject(s):
Fraud -- prevention & control
Community Health Services -- economics
Home Care Services -- economics
Insurance, Health, Reimbursement
Medicaid -- economics
Community Health Services -- organization & administration
Data Collection
Government Regulation
Health Expenditures
Home Care Services -- organization & administration
Quality Assurance, Health Care
State Government
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

147. Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions: annex 8 (R1) : sterility test general chapter

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2017
Subject(s):
Chemistry, Pharmaceutical -- standards
Drug Approval
Pharmacopoeias as Topic -- standards
Sterilization
Congresses as Topic
International Cooperation
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

148. Classification of products as drugs and devices & additional product classification issues: final guidance : guidance for industry and FDA staff

Publication:
Silver Spring, MD : Office of Combination Products, Food and Drug Administration, September 2017
Subject(s):
Biological Products -- classification
Classification -- methods
Equipment and Supplies -- classification
Pharmaceutical Preparations -- classification
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

149. Advancement of emerging technology applications for pharmaceutical innovation and modernization

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2017
Subject(s):
Biomedical Technology -- standards
Drug Industry -- standards
Inventions
Quality Assurance, Health Care
Quality Improvement
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

150. Compliance policy for required warning statements on small-packaged cigars

Publication:
Silver Spring, MD : Center for Tobacco Products, Food and Drug Administration, September 2017
Subject(s):
Product Labeling -- standards
Product Packaging -- standards
Tobacco Products -- standards
Guideline Adherence
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.